Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2000; 84(01): 145-146
DOI: 10.1055/s-0037-1613988
DOI: 10.1055/s-0037-1613988
Letters to the Editor
Transient Inhibitors in the Recombinate Pup Study
Further Information
Publication History
Received
17 December 1999
Accepted after revision
13 March 2000
Publication Date:
10 December 2017 (online)
-
References
- 1 Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G, Lee M. A multicentric study of recombinant Factor FVIII (Recombinate): safety, efficacy and inhihitor risk in previously untreated patients with hemophilia A. Blood 1994; 83: 2428-35.
- 2 Gruppo R, Chen H, Schroth P, Bray GL. for the Recombinate PUP Study Group. Safety and immunogenicity of recombinant Factor FVIII (Recombinate®) in previously untreated patients (PUPs): a 7.3 year update. Haemophilia 1998; 04: 291a.